Risultati della ricerca - D. Jaeger

  • Mostra 1 - 5 risultati su 5
Raffina i risultati
  1. 1
    Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib®versus TACE plus placebo in patients with hepatocellular cancer before liver transplantation – HeiLivCa [ISRCTN24081794]

    Prospective, randomized, double-blind, multi-center, Phase III clinical study on transarterial chemoembolization (TACE) combined with Sorafenib®versus TACE plus placebo in patients... di Katrin Hoffmann, Hanno Glimm, Boris Radeleff, Goetz M. Richter, Christoph Heining, Irini Schenkel, A. Zahlten‐Hinguranage, P Schirrmacher, Jan Schmidt, MW Büchler, D. Jaeger, Christof von Kalle, Peter Schemmer

    Pubblicazione 2008
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  2. 2
    Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CT

    Novel FAP ligands enable improved imaging contrast in sarcoma patients due to FAPI-PET/CT di Stefan A. Koerber, Rebecca Finck, Katharina Dendl, Matthias Uhl, Thomas Lindner, Clemens Kratochwil, Manuel Röhrich, Hendrik Rathke, Guy Ungerechts, Sebastian Adeberg, Klaus Herfarth, D. Jaeger, Jürgen Debus, Uwe Haberkorn, Frederik L. Giesel

    Pubblicazione 2021
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  3. 3
    Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study)

    Survival of patients with initially unresectable colorectal liver metastases treated with FOLFOX/cetuximab or FOLFIRI/cetuximab in a multidisciplinary concept (CELIM study) di Gunnar Folprecht, Thomas Gruenberger, Wolf O. Bechstein, Hans-Rudolf Raab, Jürgen Weitz, Florian Lordick, J.T. Hartmann, Jan Stoehlmacher-Williams, Hauke Lang, Tanja Trarbach, Torsten Liersch, D. Ockert, D. Jaeger, Ulrich Steger, T. Suedhoff, Anke Rentsch, C.-H. Köhne

    Pubblicazione 2014
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  4. 4
    Efficacy of pembrolizumab in phase 2 KEYNOTE-164 and KEYNOTE-158 studies of microsatellite instability high cancers

    Efficacy of pembrolizumab in phase 2 KEYNOTE-164 and KEYNOTE-158 studies of microsatellite instability high cancers di Luis A. Díaz, Aurélien Marabelle, T.W. Kim, Ravit Geva, Eric Van Cutsem, Thierry André, Paolo A. Ascierto, Michele Maio, J.P. Delord, Maya Gottfried, Rosine Guimbaud, D. Jaeger, Elena Élez, Takayuki Yoshino, Andrew K. Joe, Bao Lam, Jie Ding, Scott K. Pruitt, Soonmo Peter Kang, D. Le

    Pubblicazione 2017
    Testo
    Artigo
    Aggiungi alla lista
    Salvato in:
  5. 5
    Artificial intelligence for detection of microsatellite instability in colorectal cancer—a multicentric analysis of a pre-screening tool for clinical application

    Artificial intelligence for detection of microsatellite instability in colorectal cancer—a multicentric analysis of a pre-screening tool for clinical application di Amelie Echle, Narmin Ghaffari Laleh, Philip Quirke, Heike I. Grabsch, Hannah Sophie Muti, Oliver Lester Saldanha, Scarlet Brockmoeller, Piet A. van den Brandt, Gordon Hutchins, Susan D. Richman, Karoline Horisberger, Christian Galata, M. Ebert, Maximilian Eckardt, Michael Boutros, David Horst, Christoph Reißfelder, Elizabeth Alwers, Titus J. Brinker, Rupert Langer, Josien C.A. Jenniskens, Kelly Offermans, Wolfram Mueller, Richard Gray, Stephen B. Gruber, Joel K. Greenson, Gad Rennert, Joseph D. Bonner, Daniel Schmolze, Jenny Chang‐Claude, Hermann Brenner, Christian Trautwein, Peter Boor, D. Jaeger, Nadine T. Gaisa, Michael Hoffmeister, Nicholas P. West, Jakob Nikolas Kather

    Pubblicazione 2022
    Testo Testo
    Artigo
    Aggiungi alla lista
    Salvato in:

Strumenti per la ricerca: